Lefebvre Eric
Insider CIK 1614741 · CBAY Director · TBRA Chief Medical Officer · PLRX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2025-01-23 | 2025-01-27 | 91,300 | — | $0 | 91,300 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2025-01-23 | 2025-01-27 | 45,650 | — | $0 | 240,224 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2025-01-17 | 2025-01-22 | 18,478 | $11.20 | $207.0K | 194,574 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2024-07-10 | 2024-07-12 | 12,319 | $11.56 | $142.4K | 213,052 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2024-07-09 | 2024-07-11 | 24,063 | — | $0 | 225,371 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 14,010 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 115,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2024-01-24 | 2024-01-26 | 14,010 | — | $0 | 14,010 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2024-01-23 | 2024-01-24 | 85,800 | — | $0 | 85,800 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2024-01-23 | 2024-01-24 | 42,900 | — | $0 | 199,820 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2024-01-17 | 2024-01-19 | 10,295 | $17.23 | $177.4K | 156,920 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-07-17 | 2023-07-19 | 22,321 | $18.01 | $402.0K | 167,215 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2023-07-14 | 2023-07-18 | 43,750 | — | $0 | 189,536 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-03-30 | 2023-04-03 | 11,245 | $26.52 | $298.2K | 145,786 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2023-03-29 | 2023-03-31 | 21,874 | — | $0 | 157,031 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2023-01-25 | 2023-01-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2023-01-25 | 2023-01-27 | 80,000 | — | $0 | 80,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2023-01-25 | 2023-01-27 | 57,000 | — | $0 | 133,926 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-23 | 2023-01-25 | 67,500 | $34.48 | $2.33M | 76,926 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2022-12-20 | 2022-12-21 | 10,887 | $19.10 | $207.9K | 144,426 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2022-12-19 | 2022-12-21 | 21,876 | — | $0 | 155,313 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2022-10-25 | 2022-10-27 | 5,000 | $25.05 | $125.3K | 133,437 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2022-07-11 | 2022-07-13 | 3,000 | $20.00 | $60.0K | 138,436 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2022-03-21 | 2022-03-21 | 115,000 | — | $0 | 115,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2022-01-26 | 2022-02-02 | 140,000 | — | $0 | 140,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-06-18 | 2021-06-22 | 3,728 | $29.43 | $109.7K | 137,102 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-06-18 | 2021-06-22 | 22 | $30.23 | $665 | 137,080 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-06-18 | 2021-06-22 | 8,750 | $28.62 | $250.4K | 140,830 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-03-18 | 2021-03-19 | 11,365 | $39.38 | $447.6K | 150,715 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-03-18 | 2021-03-19 | 1,135 | $39.78 | $45.2K | 149,580 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2021-01-23 | 2021-01-26 | 73,250 | — | $0 | 73,250 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2020-12-18 | 2020-12-21 | 5,712 | $26.98 | $154.1K | 162,080 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2020-12-18 | 2020-12-21 | 6,788 | $26.17 | $177.6K | 167,792 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 100,000 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 101,000 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 79,287 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2016-01-12 | 2016-01-14 | 101,000 | — | $0 | 101,000 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2015-05-15 | 2015-05-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 79,287 | — | $0 | 79,287 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 21,607 | — | $0 | 100,894 | SEC↗ |